Diversified Trust CO Pulmonx Corp Transaction History

Diversified Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	SELL	$4.92 - $17.35 $5,289 - $18,651	-1,075 Reduced 6.41%	15,700 $132,000
Q3 2022 Oct 14, 2022	BUY	$15.35 - $23.99 $56,795 - $88,763	3,700 Added 28.3%	16,775 $279,000
Q2 2022 Jul 12, 2022	BUY	$14.0 - $27.95 $4,550 - $9,083	325 Added 2.55%	13,075 $192,000
Q1 2022 Apr 07, 2022	BUY	$21.13 - $35.65 $42,788 - $72,191	2,025 Added 18.88%	12,750 $316,000
Q4 2021 Jan 13, 2022	BUY	$29.72 - $45.1 $34,921 - $52,992	1,175 Added 12.3%	10,725 $344,000
Q3 2021 Jan 13, 2022	BUY	$35.98 - $44.48 $168,206 - $207,943	4,675 Added 95.9%	9,550 $344,000
Q2 2021 Jul 20, 2021	BUY	$37.61 - $48.0 $183,348 - $234,000	4,875 New	4,875 $215,000

128

31.8M

2.6K

216K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $59.3M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.